We postulated that the anti-myeloma effects of combination Tra/Pon treatment were abrogated by their unfavorable impacts on non-myeloma cells, such as myeloma killing cytotoxic CD8+ T cells. This evidence concerns the gene CD8A and plasma cell myeloma.